HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A myxoid chondrosarcoma associated with an anti-Hu-positive paraneoplastic encephalomyelitis.

Abstract
Extraskeletal myxoid chondrosarcoma is a rare tumor with less than 100 cases reported in the literature. The prevalence of anti-Hu positive myxoid chondrosarcoma-associated paraneoplastic subacute cerebellar degeneration is exceedingly rare. We present a report of a patient with confirmed myxoid chondrosarcoma-associated paraneoplastic subacute cerebellar degeneration, who exhibited marked improvement within 1 week of receiving chemotherapy, intravenous immunoglobulin (IVIG), and hydrocortisone treatment.
AuthorsMichael Hoosien, James Vredenburgh, Julio Lanfranco, Roberto Ochoa, Philip Robinson, Robert Martinez, Carlos Singer, Orlando Silva
JournalJournal of neuro-oncology (J Neurooncol) Vol. 101 Issue 1 Pg. 135-9 (Jan 2011) ISSN: 1573-7373 [Electronic] United States
PMID20443130 (Publication Type: Case Reports, Journal Article)
Chemical References
  • ELAV Proteins
  • Immunoglobulins, Intravenous
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Chondrosarcoma (complications, drug therapy, surgery)
  • ELAV Proteins (immunology)
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Male
  • Middle Aged
  • Paraneoplastic Syndromes, Nervous System (drug therapy, etiology, physiopathology)
  • Soft Tissue Neoplasms (complications, drug therapy, surgery)
  • Thigh

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: